Related Experiment Videos
Novel bisbenzamidines and bisbenzimidazolines as noncompetitive NMDA receptor antagonists
1College of Pharmacy, Xavier University of Louisiana, New Orleans 70125, USA.
Bioorganic & Medicinal Chemistry Letters
|May 26, 1999
Abstract:
A series of novel bisbenzamidines and bisbenzimidazolines with different linkers connecting the aromatic groups was tested in vitro for NMDA receptor antagonist activity. IC50 values for these compounds ranged from 1.2 to >200 microM. The bisbenzamidine with a homopiperazine ring as the central linker was found to be the most potent NMDA receptor antagonist among all the pentamidine analogues tested so far.